Recurrent GRHL fusions in a subset of sebaceoma: microscopic and molecular characterisation of eight cases

Mélanie Legrand1, Baptiste Louveau2, Nicolas Macagno3,4

  • 1Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.

Histopathology
|November 20, 2024
PubMed
Abstract

Insights

Genetic rearrangements involving GRHL genes were identified in a specific group of sebaceomas. These sebaceomas show unique microscopic features and lack mismatch repair deficiency, suggesting a distinct tumor subtype.

Area of Science:

  • Dermatopathology
  • Oncology
  • Molecular Genetics

Background:

  • Sebaceous neoplasms, including adenoma, sebaceoma, and carcinoma, are skin adnexal tumors.
  • The genetic drivers for most sebaceous neoplasms remain largely unknown, despite potential associations with mismatch repair deficiency.

Purpose of the Study:

  • To investigate the clinical, microscopic, and molecular characteristics of sebaceomas associated with GRHL gene rearrangements.
  • To identify specific genetic alterations contributing to the development of a subset of sebaceomas.

Main Methods:

  • Analysis of eight sebaceomas using clinical, microscopic, and molecular techniques.
  • RNA-sequencing to identify gene fusions, including those involving GRHL genes.
  • Immunohistochemistry for mismatch repair proteins and methylation analysis.

Main Results:

  • Eight sebaceomas (median age 63 years) were identified, all located in the head and neck region.
  • Tumors exhibited macronodular, cribriform, and organoid growth patterns with infundibulocystic differentiation and immature sebocytes.
  • Recurrent GRHL gene fusions (e.g., RCOR1::GRHL2, BCL6::GRHL1) were detected, forming an independent molecular cluster related to poromas.

Conclusions:

  • Recurrent GRHL gene fusions define a distinct subset of sebaceomas.
  • These sebaceomas are characterized by infundibulocystic differentiation, organoid growth, and intact mismatch repair.
  • The findings suggest a unique molecular pathogenesis for this specific group of sebaceous neoplasms.